1. Market Research
  2. > ICT
  3. > Telecom
  4. > Mobile Services Market Trends
Benchmarking Biologic Innovator Value-Added-Services

Benchmarking Biologic Innovator Value-Added-Services

  • November 2016
  • ID: 4699258
  • Format: PDF
  • Firstword Pharma

Summary

Table of Contents

Description

Delivering high-quality value-added services for biologics

What are the “beyond-the-pill” services that biologic companies need to deliver to ensure improved patient compliance and outcomes?

Patient, payer and clinical expectations of biologic drugs are high and developers must go the extra mile to support all stakeholders and see patient outcomes improve. Value-added services (VAS), from financial support to treatment compliance tools, are commonplace in pharma, so what more must biologic developers do and how can that be achieved?

To establish which VAS are appropriate, identify the challenges specific to biologics, design winning programmes and gain competitive advantage, turn to this expert report Benchmarking Biologic Innovator Value-Added-Services.

Key Features
- In-depth interviews with biologic industry experts in the US, France, Germany, Italy, Spain and the UK reveal unique insights gained from their front line experience
- A listing of innovative VAS and Patient Assistance Programmes of the top 15 biological manufacturers
- Case studies including Biogen Idec’s Above MS programme and Abbvie’s model for taking a diversified approach to VAS
- Extensive secondary research which puts expert commentary into wider market context
- At-a-glance summaries of all the main insights

Key Benefits
- Understand the unique circumstances that influence the design and delivery of biologic VAS
- Identify the benefits of VAS to payers, patients and health providers
- Learn how cutting-edge technology partnering can accelerate your VAS delivery
- Establish how VAS benefits need to be nuanced in the US and EU5 countries
- Know when to start planning you VAS programme – it may be earlier than you think!
- Harness the power of patients to really understand their conditions and deliver VAS that will be most beneficial
- Understand the unique challenges facing biosimilar developers.

Key Questions Answered by This Report:
- Special biologics drivers: What are the specific clinical, payer and patient drivers that shape the delivery of biologic VAS?
- Patient voice: In what practical ways can patient input determine the delivery of an optimum VAS programme?
- Timing: When should you start planning your VAS programme and what are the risks of being too late or too early?
- Technology: How have advances in technology changed the VAS landscape and how can biologic developers benefit?
- National view: Why do VAS programmes need to be created or adapted to patient needs in each country?
- Support: What are the challenges of getting internal cross-functional support for your VAS project?

Expert Views
To ensure candid views were expressed, some expert names have been kept anonymous, but each has been vetted for their experience and detailed current knowledge of VAS issues.
- Associate Director of US Marketing, small biotech, US
- Jay Humphrey, Global Marketing Director, Takeda Oncology
- Vice President of Outcomes Research, Top 20 Pharma Company, US
- Julie O’Donnell, former Global Head of Customer Interaction at Lundbeck, Current CEO of One15 Healthcare
- Senior Vice President, Top 20 Pharma Company, Europe
- Value-added services specialist, Europe
- Healthcare Solutions Lead, Top 20 Pharma Company, US

Key Quotes
“The worst thing that can happen is that the doctor says this is the patient, this is the drug, and then something happens in between the prescription being written and the patient taking the medicine. It is on us as the manufacturer to make sure that that [interference] doesn't happen.”
Associate Director of US Marketing Small Biotech, US<

“We've heard many, many times from patients and patient advocates that a lot of the [patient-facing disease] information is either hyperbole, potentially scary, or if it's very scientifically minded, very difficult to navigate. So trying to provide if not peer reviewed or scientifically reviewed information with regard to a disease state, being able to point to similar information that may exist to allow for a patient to really become educated and empowered.” Jay Humphrey Takeda

“A lot of times patients, physicians, payers are not even aware of the services that we do provide. In many ways it is a challenge for us to let people know what we can actually provide for them as part of these value-added services. So we should probably do a better job than we do in regard to informing people of these services.” Vice President Top 20 Pharma Company, US

Who will benefit from this report?
- Teams developing VAS programmesMedical affairs teams needing knowledge of VAS for their clinical engagements
- Market access/KAM teams charged with presenting inclusive commercial propositions to payers
- Brand and marketing professionals wanting to position products for competitive advantage
- Patient engagement teams
- Regulatory and legal professionals ensuring VAS programmes are compliant
- National and regional payers assessing overall value
- Patient advocacy groups wanting VAS programmes that really meet need
- Industry professionals charged with commissioning digital technology solutions
- Technology companies wanting to expand use of their novel VAS and communication technologies

Content Highlights
Executive summary
- What is the definition of value-added services?
- What value-added services are there?
- Unique challenges for biological manufacturers
- Changing and evolving
- Why do companies develop value-added services?
- The benefit to patients
- The benefit to healthcare providers
- The benefit to payers
- The benefit to biological manufacturers
- The process of developing value-added services
- How should value-added services be aligned within companies?
- Who should provide input on value-added services?
- Internal and external considerations for rolling out value-added services
- Working with external sources
- Promoting value-added services
- Critical success factors for value-added services
- Challenges for value-added services
- Working in siloes
- Daunting financial investments
- Difficulty achieving buy-in
- Fears about meeting consumer expectations
- Gauging success in value-added services
- Measuring return on investment
- The value of feedback
- What is the future of value-added services?
- Increased focus on patient needs
- Increased use of data
- Increased risk sharing/partnering
- Increased need for product differentiation

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2016

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on